Targeting TROP2 in Breast Cancer: How Experts are Integrating TROP2 ADCs into Clinical Practice

Get up to date on approved and emerging TROP-2–targeted antibody–drug conjugates in triple-negative and hormone receptor–positive advanced breast cancer with downloadable slides and an archived webcast from a live workshop developed for the oncology multidisciplinary care team.

Share

Program Content

Activities

TROP-2 ADCs in Breast Cancer
Targeting TROP-2 in Breast Cancer: How Experts Are Integrating TROP-2 ADCs Into Clinical Practice
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 11, 2023

Activities

TROP2 ADCs in Breast Cancer 2023
TROP-2 in Breast Cancer: How to Integrate ADCs Into Clinical Practice
Video
Congratulations: You achieved a completion on 04/09/2022

Released: November 09, 2023

Expires: November 08, 2024

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.